金投网

Higher margin, higher quality. Initiate coverage at OW

  招商证券(06099)   We initiate coverage of China Merchant Securities (CMS) with an OW ratingand a Dec-17 PT of HK$15.5. We believe the business strategy of prioritizingprofit margins over volume growth and noted emphasis on risk management willposition it for superior growth and stronger/more stable margin vs peers.   Emphasis on margins: CMS is differentiated from peers by focusing more onhigher margin segments such as institutional customers, where it ranks first for trading volume with mutual funds and prime brokerage services with PE funds in China, and HNW individuals via its Zhiyuan WM plans for equity brokerage,SME/NEEQ/ABS for equity/debt underwriting, and collective asset management schemes on AM businesses. CMS thus is able to enjoy superior commission rates on average and deliver the highest ROA among H-share listed brokers.   Stronger risk management: CMS is one of the few brokers to maintain an AAregulatory rating in 2016, while other leading H-share listed peers weredowngraded. The regulatory rating is beneficial to earnings, as it helps limitcontributions to investors’ protection funds and benefit funding costs. It also supports higher capital efficiency and facilitates new business development that is crucial for institutional businesses   Investment risks: 1) Risks related to contributions to the governmentstabilization fund (the CSFC) and ban on hedging; 2) tighter regulatorysupervision on the rapidly emerging domestic asset management businesses;3) long-term pressure on brokerage commission rates due to the development ofonline/mobile industry platforms and fragmented market conditions, combinedwith uncertainties from potential deregulation of brokerage fee structure   Valuation: We expect CMS to deliver superior ROA through the cycle on theback of its more stable commission rates, focuses on higher margin segments,and better capital efficiency. Based on our DDM model, our Dec-17 PT ofHK$15.5 implies 1.5x and 1.4x FY16/17E P/B and 15x and 11x FY16/17E P/E.
免责声明 金投网发布此信息目的在于传播更多信息,与本网站立场无关。金投网不保证该信息(包括但不限于文字、数据及图表)全部或者部分内容的准确性、真实性、完整性、有效性、及时性、原创性等。相关信息并未经过本网站证实,不对您构成任何投资建议,据此操作,风险自担。
代码 名称 最新价(港元) 涨幅
01862 景瑞控股 0.14 238.1
00708 恒大健康 0.38 53.23
01396 毅德国际 0.75 47.06
02329 国瑞置业 0.08 46.15
08161 医汇集团 0.43 43.33

港股频道HKSTOCK.CNGOLD.ORG